Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-03-27FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine), a pen formulation, filed by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-03-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company. The notice indicates a supplemental approval rela…
-
FDA approval · 2013-03-11FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25, a premixed insulin lispro product manufactured by Eli Lilly and Company.
-
FDA approval · 2013-03-11FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-03-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro (Humalog) submitted by Eli Lilly and Company. The approval confirms the supplemen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-03-09FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for the insulin aspart protamine and insulin aspart mix 70/30 product, confirming continued regu…
-
FDA approval · 2013-03-09FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approves NovoLog (insulin aspart) supplemental application submitted by Novo Nordisk. The approval updates the labeling and/or indicatio…
-
FDA approval · 2013-03-09FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk, adding regulatory clearance for the product. This a…
-
FDA approval · 2013-02-21FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-02-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-02-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.
-
FDA approval · 2013-01-30FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-01-30FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2012-12-13FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for Novo Nordisk’s insulin aspart protamine and insulin aspart mix 70/30.
-
FDA approval · 2012-11-07FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2012-11-05FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2012-11-05FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approves NovoLOG's supplemental application for insulin aspart submitted by Novo Nordisk, updating the approved product.
-
FDA approval · 2012-04-27FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk.
-
FDA approval · 2012-03-29FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk, resulting in changes to its labeling.
-
FDA approval · 2012-03-21FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2012-03-21FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2012-03-21FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN, a premixed insulin lispro product, to be delivered via the KWIKPEN…